PHATHOM PHARMACEUTICALS INC shareholders Q3 2023

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

PHATHOM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ExodusPoint Capital Management, LP 17,008$1760.00%
HEADINVEST, LLC 882$8,9520.00%
TWO SIGMA INVESTMENTS, LP 84,063$871,7330.00%
Centiva Capital, LP 10,962$113,6760.00%
FEDERATED HERMES, INC. 82,148$851,8750.00%
Walleye Capital LLC 85,372$885,3080.00%
Allworth Financial LP 19,580$203,0450.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,818$18,8530.00%
MetLife Investment Management, LLC 16,471$170,8040.00%
Tradition Wealth Management, LLC 500$50.00%
D. E. Shaw & Co., Inc. 130,564$1,353,9490.00%
Ameritas Investment Partners, Inc. 3,095$32,0950.00%
RHUMBLINE ADVISERS 56,537$586,2760.00%
AMERICAN INTERNATIONAL GROUP, INC. 15,409$159,7910.00%
Nuveen Asset Management, LLC 287,834$2,984,8390.00%
NORTHERN TRUST CORP 268,776$2,787,2070.00%
GEODE CAPITAL MANAGEMENT, LLC 682,570$7,079,1270.00%
MILLENNIUM MANAGEMENT LLC 139,348$1,445,0390.00%
SG Americas Securities, LLC 12,164$1260.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 246,681$2,558,0820.00%
External links

This page lists PHATHOM PHARMACEUTICALS INC's shareholders in Q3 2023. To view PHATHOM PHARMACEUTICALS INC's shareholder history, click here.